During the past decade, Southern Oncology Specialists-Huntersville conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 22 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 19 clinical trials were completed. i.e. 633.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Oncology Specialists-Huntersville" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Oncology Specialists-Huntersville" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Southern Oncology Specialists-Huntersville" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (5 trials), "Ovarian Serous Adenocarcinoma" (3 trials) and "Primary Peritoneal Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Southern Oncology Specialists-Huntersville" in a lesser frequency.

Most popular intervention types in "Southern Oncology Specialists-Huntersville" are "Drug" (39 trials), "Other" (34 trials), "Biological" (16 trials), "Procedure" (9 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (9 trials), "Docetaxel" (8 trials), "Questionnaire Administration" (7 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Southern Oncology Specialists-Huntersville" are 34 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Oncology Specialists-Huntersville". undefined are not yet recruiting, 7 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Southern Oncology Specialists-Huntersville, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Oncology Specialists-Huntersville, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".